Drug Patents owned by Cubist Pharms

1. List of Entereg drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946262 CUBIST PHARMS Methods of preventing and treating gastrointestinal dysfunction
Feb, 2030

(6 years from now)

Drugs and Companies using ALVIMOPAN ingredient

Market Authorisation Date: 20 May, 2008

Treatment: A method to accelerate the time to gastrointestinal recovery by administering about 12 mg of alvimopan to the patient from about 30 to 60 minutes prior to surgery


How can I launch a generic of ENTEREG before it's patent expiration?
More Information on Dosage

ENTEREG family patents


United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic